289 Views

Session: Slow and Steady: Insights Into Nontuberculous Mycobacteria and Treatment

817 - Evolution of Drug Resistance in Mycobacterium abscessus

Friday, October 21, 2022

8:30 AM – 9:00 AM US ET

Location: 209 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Keira A. Cohen, MD (she/her/hers)

Senior Medical Director
Janssen Pharmaceuticals
Baltimore, MD, United States

Disclosure: Disclosure(s): AN2 Therapeutics, Inc.: Advisor/Consultant (Terminated); Hill-Rom, Inc: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Insmed Inc: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Janssen Pharmaceutical Company of J&J: Employee (Ongoing); Microbion, Inc: Advisor/Consultant (Terminated); Paratek Pharmaceuticals: Advisor/Consultant (Terminated)

Disclosure(s):

Keira A. Cohen, MD: AN2 Therapeutics, Inc.: Advisor/Consultant (Terminated); Hill-Rom, Inc: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Insmed Inc: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Janssen Pharmaceutical Company of J&J: Employee (Ongoing); Microbion, Inc: Advisor/Consultant (Terminated); Paratek Pharmaceuticals: Advisor/Consultant (Terminated)